Clinical Trials Browser

Terminated × MAGEA3 protein, human × Clear all

NCT01307618 2016-10-24

Vaccine Therapy With or Without Recombinant Interleukin-12 Followed by Daclizumab in Treating Patients With Metastatic Melanoma

Phase 2 Terminated

10 enrolled 8 charts

Melanoma